BRAIN Biotech specializes in industrial biotechnology, focusing on creating sustainable products and processes through advanced biotechnological methods. Their core technologies include genome editing, customized enzyme development, and bioprocess development. The company utilizes alternative genome editing tools, such as CRISPR, to facilitate rapid and cost-effective project outcomes. They also excel in identifying and optimizing enzymes and biocatalysts tailored to meet complex industrial requirements. Their bioprocess development unit operates as a Contract Research Organization (CRO), where they design, optimize, and scale up microbial production processes, ensuring that these processes are efficient and competitive in various markets, including food, chemicals, and healthcare.

In addition to enzyme and bioprocess development, BRAIN Biotech emphasizes microbial strain development, leveraging their extensive collection of natural resources to create optimized production strains. Their interdisciplinary approach combines scientific expertise with practical application, allowing them to deliver innovative solutions that address the specific needs of their industry partners. The company is committed to sustainability and aims to contribute to a circular economy by developing bio-based products and processes that are environmentally friendly. Through collaboration with clients, BRAIN Biotech seeks to advance the development of novel biotechnological solutions that enhance market differentiation and promote a biobased future.

Germany

BRAIN Biotech AG is a leading European supplier of enzyme products, production strains and bioprocess solutions for more sustainable and efficient industrial processes. We focus on the fields of nutrition, health and environment.

BRAIN Biotech AG is the parent company of the international BRAIN Biotech Group. The Group's business activities are divided into the segments BioProducts, BioScience and BioIncubator.

Brain Biotech

Company Details